{"id":59312,"date":"2024-05-03T19:03:21","date_gmt":"2024-05-03T17:03:21","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/hematology-collaboration-and-licensing-partnering-analysis-report-2024-with-directory-of-deals-signed-since-2016-researchandmarkets-com\/"},"modified":"2024-05-03T19:03:21","modified_gmt":"2024-05-03T17:03:21","slug":"hematology-collaboration-and-licensing-partnering-analysis-report-2024-with-directory-of-deals-signed-since-2016-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/hematology-collaboration-and-licensing-partnering-analysis-report-2024-with-directory-of-deals-signed-since-2016-researchandmarkets-com\/","title":{"rendered":"Hematology Collaboration and Licensing Partnering Analysis Report 2024 with Directory of Deals Signed Since 2016 &#8211; ResearchAndMarkets.com"},"content":{"rendered":"<div>\n<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/report\/hematology?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=sk4s76&amp;utm_campaign=1959545+-+Hematology+Collaboration+and+Licensing+Partnering+Analysis+Report+2024+with+Directory+of+Deals+Signed+Since+2016&amp;utm_exec=chdomspi\" rel=\"nofollow noopener\" shape=\"rect\">&#8220;Hematology Collaboration and Licensing Deals 2016-2024&#8221;<\/a> report has been added to <strong>ResearchAndMarkets.com&#8217;s<\/strong> offering.<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20240503117955\/en\/2119271\/4\/logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20240503117955\/en\/2119271\/22\/logo.jpg\"><\/a><br \/><a href=\"https:\/\/mms.businesswire.com\/media\/20240503117955\/en\/2119271\/4\/logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20240503117955\/en\/2119271\/21\/logo.jpg\"><\/a><\/p>\n<p>\nHematology Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the hematology deals entered into by the worlds leading biopharma companies. Fully revised and updated, the report provides details of hematology deals from 2016 to 2024. The report provides access to deal payment terms as announced between the parties. This data provides useful insight into the payment and other deal terms.<\/p>\n<p>\nUnderstanding the flexibility of a prospective partner&#8217;s negotiated deal terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered and rights transferred &#8211; contract documents provide this insight where press releases and databases do not.<\/p>\n<p>\nThis report contains a comprehensive listing of collaboration and licensing deals announced since 2016 as recorded in the Current Agreements deals and alliances database, including financial terms where available, plus links to online copies of actual licensing contract documents as submitted to the Securities Exchange Commission by companies and their partners.<\/p>\n<p>\nThe initial chapters of this report provide an orientation of hematology dealmaking and business activities. Chapter 1 provides an introduction to the report, whilst chapter 2 provides an analysis of the trends in hematology dealmaking.<\/p>\n<p>\nChapter 3 covers the financial deal terms for deals signed in the hematology field with stage of development announced. Deals are listed and sectioned by headline value, upfront payment, milestone payment and royalty rates.<\/p>\n<p>\nChapter 4 provides a review of the top 25 most active biopharma companies in hematology dealmaking. Where the deal has an agreement contract published at the SEC a link provides online access to the contract via the Current Agreements deals and alliances database.<\/p>\n<p>\nChapter 5 provides a comprehensive and detailed review of hematology deals signed and announced since 2016 where a contract document is available. Each deal title links via Weblink to an online version of the actual contract document, providing easy access to each contract document on demand.<\/p>\n<p>\nChapter 6 provides a comprehensive directory of hematology deals listed by therapeutic target.<\/p>\n<p>\nThe report also includes numerous table and figures that illustrate the trends and activities in hematology deal making since 2016.<\/p>\n<p>\n<strong>Key Benefits<\/strong><\/p>\n<ul>\n<li>\nUnderstand deal trends since 2016<\/li>\n<li>\nBrowse hematology collaboration and licensing deals<\/li>\n<li>\nBenchmark analysis &#8211; identify market value of transactions<\/li>\n<li>\nFinancials terms &#8211; upfront, milestone, royalties<\/li>\n<li>\nDirectory of deals by company A-Z, therapy focus and technology type<\/li>\n<li>\nLeading deals by value<\/li>\n<li>\nMost active dealmakers<\/li>\n<li>\nIdentify assets and deal terms for each transaction<\/li>\n<li>\nAccess contract documents &#8211; insights into deal structures<\/li>\n<li>\nDue diligence &#8211; assess suitability of your proposed deal terms for partner companies<\/li>\n<li>\nSave hundreds of hours of research time<\/li>\n<\/ul>\n<p>\n<strong>Analyzing contract agreements allows due diligence of:<\/strong><\/p>\n<ul>\n<li>\nWhat are the precise rights granted or optioned?<\/li>\n<li>\nWhat is actually granted by the agreement to the partner company?<\/li>\n<li>\nWhat exclusivity is granted?<\/li>\n<li>\nWhat is the payment structure for the deal?<\/li>\n<li>\nHow are sales and payments audited?<\/li>\n<li>\nWhat is the deal term?<\/li>\n<li>\nHow are the key terms of the agreement defined?<\/li>\n<li>\nHow are IPRs handled and owned?<\/li>\n<li>\nWho is responsible for commercialization?<\/li>\n<li>\nWho is responsible for development, supply, and manufacture?<\/li>\n<li>\nHow is confidentiality and publication managed?<\/li>\n<li>\nHow are disputes to be resolved?<\/li>\n<li>\nUnder what conditions can the deal be terminated?<\/li>\n<li>\nWhat happens when there is a change of ownership?<\/li>\n<li>\nWhat sublicensing and subcontracting provisions have been agreed?<\/li>\n<li>\nWhich boilerplate clauses does the company insist upon?<\/li>\n<li>\nWhich boilerplate clauses appear to differ from partner to partner or deal type to deal type?<\/li>\n<li>\nWhich jurisdiction does the company insist upon for agreement law?<\/li>\n<\/ul>\n<p>\n<strong>Key Topics Covered:<\/strong><\/p>\n<p>\n<strong>Chapter 1 &#8211; Introduction<\/strong><\/p>\n<p>\n<strong>Chapter 2 &#8211; Trends in hematology dealmaking<\/strong><\/p>\n<p>\n2.1. Introduction<\/p>\n<p>\n2.2. Hematology partnering over the years<\/p>\n<p>\n2.3. Hematology partnering by deal type<\/p>\n<p>\n2.4. Hematology partnering by industry sector<\/p>\n<p>\n2.5. Hematology partnering by stage of development<\/p>\n<p>\n2.6. Hematology partnering by technology type<\/p>\n<p>\n2.7. Hematology partnering by therapeutic indication<\/p>\n<p>\n<strong>Chapter 3 &#8211; Financial deal terms for hematology partnering<\/strong><\/p>\n<p>\n3.1. Introduction<\/p>\n<p>\n3.2. Disclosed financials terms for hematology partnering<\/p>\n<p>\n3.3. Hematology partnering headline values<\/p>\n<p>\n3.4. Hematology deal upfront payments<\/p>\n<p>\n3.5. Hematology deal milestone payments<\/p>\n<p>\n3.6. Hematology royalty rates<\/p>\n<p>\n<strong>Chapter 4 &#8211; Leading hematology deals and dealmakers<\/strong><\/p>\n<p>\n4.1. Introduction<\/p>\n<p>\n4.2. Most active in hematology partnering<\/p>\n<p>\n4.3. List of most active dealmakers in hematology<\/p>\n<p>\n4.4. Top hematology deals by value<\/p>\n<p>\n<strong>Chapter 5 &#8211; Hematology contract document directory<\/strong><\/p>\n<p>\n5.1. Introduction<\/p>\n<p>\n5.2. Hematology partnering deals where contract document available<\/p>\n<p>\n<strong>Chapter 6 &#8211; Hematology dealmaking by therapeutic target<\/strong><\/p>\n<p>\n6.1. Introduction<\/p>\n<p>\n6.2. Deals by hematology therapeutic target<\/p>\n<p>\n<strong>Deal directory<\/strong><\/p>\n<ul>\n<li>\nDeal directory &#8211; Hematology deals by company A-Z 2016 to 2024<\/li>\n<li>\nDeal directory &#8211; Hematology deals by technology type 2016 to 2024<\/li>\n<li>\nDeal type definitions<\/li>\n<\/ul>\n<p>\nFor more information about this report visit <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/report\/hematology?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=sk4s76&amp;utm_campaign=1959545+-+Hematology+Collaboration+and+Licensing+Partnering+Analysis+Report+2024+with+Directory+of+Deals+Signed+Since+2016&amp;utm_exec=chdomspi\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/www.researchandmarkets.com\/r\/b0teod<\/a><\/p>\n<p>\n<strong>About ResearchAndMarkets.com<\/strong><\/p>\n<p>\nResearchAndMarkets.com is the world&#8217;s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nResearchAndMarkets.com<br \/>\n<br \/>Laura Wood, Senior Press Manager<br \/>\n<br \/><a target=\"_blank\" href=\"ma&#105;&#108;&#116;&#111;&#x3a;&#x70;&#x72;&#x65;&#x73;s&#64;&#114;&#101;&#115;&#101;&#x61;&#x72;&#x63;&#x68;&#x61;nd&#109;&#97;&#114;&#107;&#x65;&#x74;&#x73;&#x2e;&#x63;om\" rel=\"nofollow noopener\" shape=\"rect\">&#112;&#x72;&#101;&#x73;&#115;&#x40;&#114;&#x65;&#115;&#x65;&#97;&#x72;&#99;&#x68;&#97;&#x6e;&#100;&#x6d;&#97;&#x72;&#107;&#x65;&#116;&#x73;&#46;&#x63;o&#x6d;<\/a><\/p>\n<p>For E.S.T Office Hours Call 1-917-300-0470<br \/>\n<br \/>For U.S.\/ CAN Toll Free Call 1-800-526-8630<br \/>\n<br \/>For GMT Office Hours Call +353-1-416-8900<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Hematology Collaboration and Licensing Deals 2016-2024&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. Hematology Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the hematology deals entered into by the worlds leading biopharma companies. Fully revised and updated, the report provides details of hematology deals from 2016 to 2024. The &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/hematology-collaboration-and-licensing-partnering-analysis-report-2024-with-directory-of-deals-signed-since-2016-researchandmarkets-com\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-59312","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Hematology Collaboration and Licensing Partnering Analysis Report 2024 with Directory of Deals Signed Since 2016 - ResearchAndMarkets.com - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/hematology-collaboration-and-licensing-partnering-analysis-report-2024-with-directory-of-deals-signed-since-2016-researchandmarkets-com\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Hematology Collaboration and Licensing Partnering Analysis Report 2024 with Directory of Deals Signed Since 2016 - ResearchAndMarkets.com - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Hematology Collaboration and Licensing Deals 2016-2024&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. Hematology Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the hematology deals entered into by the worlds leading biopharma companies. Fully revised and updated, the report provides details of hematology deals from 2016 to 2024. The ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/hematology-collaboration-and-licensing-partnering-analysis-report-2024-with-directory-of-deals-signed-since-2016-researchandmarkets-com\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2024-05-03T17:03:21+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20240503117955\/en\/2119271\/22\/logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/hematology-collaboration-and-licensing-partnering-analysis-report-2024-with-directory-of-deals-signed-since-2016-researchandmarkets-com\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/hematology-collaboration-and-licensing-partnering-analysis-report-2024-with-directory-of-deals-signed-since-2016-researchandmarkets-com\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Hematology Collaboration and Licensing Partnering Analysis Report 2024 with Directory of Deals Signed Since 2016 &#8211; ResearchAndMarkets.com\",\"datePublished\":\"2024-05-03T17:03:21+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/hematology-collaboration-and-licensing-partnering-analysis-report-2024-with-directory-of-deals-signed-since-2016-researchandmarkets-com\\\/\"},\"wordCount\":874,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/hematology-collaboration-and-licensing-partnering-analysis-report-2024-with-directory-of-deals-signed-since-2016-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20240503117955\\\/en\\\/2119271\\\/22\\\/logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/hematology-collaboration-and-licensing-partnering-analysis-report-2024-with-directory-of-deals-signed-since-2016-researchandmarkets-com\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/hematology-collaboration-and-licensing-partnering-analysis-report-2024-with-directory-of-deals-signed-since-2016-researchandmarkets-com\\\/\",\"name\":\"Hematology Collaboration and Licensing Partnering Analysis Report 2024 with Directory of Deals Signed Since 2016 - ResearchAndMarkets.com - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/hematology-collaboration-and-licensing-partnering-analysis-report-2024-with-directory-of-deals-signed-since-2016-researchandmarkets-com\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/hematology-collaboration-and-licensing-partnering-analysis-report-2024-with-directory-of-deals-signed-since-2016-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20240503117955\\\/en\\\/2119271\\\/22\\\/logo.jpg\",\"datePublished\":\"2024-05-03T17:03:21+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/hematology-collaboration-and-licensing-partnering-analysis-report-2024-with-directory-of-deals-signed-since-2016-researchandmarkets-com\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/hematology-collaboration-and-licensing-partnering-analysis-report-2024-with-directory-of-deals-signed-since-2016-researchandmarkets-com\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/hematology-collaboration-and-licensing-partnering-analysis-report-2024-with-directory-of-deals-signed-since-2016-researchandmarkets-com\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20240503117955\\\/en\\\/2119271\\\/22\\\/logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20240503117955\\\/en\\\/2119271\\\/22\\\/logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/hematology-collaboration-and-licensing-partnering-analysis-report-2024-with-directory-of-deals-signed-since-2016-researchandmarkets-com\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Hematology Collaboration and Licensing Partnering Analysis Report 2024 with Directory of Deals Signed Since 2016 &#8211; ResearchAndMarkets.com\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Hematology Collaboration and Licensing Partnering Analysis Report 2024 with Directory of Deals Signed Since 2016 - ResearchAndMarkets.com - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/hematology-collaboration-and-licensing-partnering-analysis-report-2024-with-directory-of-deals-signed-since-2016-researchandmarkets-com\/","og_locale":"en_US","og_type":"article","og_title":"Hematology Collaboration and Licensing Partnering Analysis Report 2024 with Directory of Deals Signed Since 2016 - ResearchAndMarkets.com - Pharma Trend","og_description":"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Hematology Collaboration and Licensing Deals 2016-2024&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. Hematology Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the hematology deals entered into by the worlds leading biopharma companies. Fully revised and updated, the report provides details of hematology deals from 2016 to 2024. The ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/hematology-collaboration-and-licensing-partnering-analysis-report-2024-with-directory-of-deals-signed-since-2016-researchandmarkets-com\/","og_site_name":"Pharma Trend","article_published_time":"2024-05-03T17:03:21+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20240503117955\/en\/2119271\/22\/logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/hematology-collaboration-and-licensing-partnering-analysis-report-2024-with-directory-of-deals-signed-since-2016-researchandmarkets-com\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/hematology-collaboration-and-licensing-partnering-analysis-report-2024-with-directory-of-deals-signed-since-2016-researchandmarkets-com\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Hematology Collaboration and Licensing Partnering Analysis Report 2024 with Directory of Deals Signed Since 2016 &#8211; ResearchAndMarkets.com","datePublished":"2024-05-03T17:03:21+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/hematology-collaboration-and-licensing-partnering-analysis-report-2024-with-directory-of-deals-signed-since-2016-researchandmarkets-com\/"},"wordCount":874,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/hematology-collaboration-and-licensing-partnering-analysis-report-2024-with-directory-of-deals-signed-since-2016-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20240503117955\/en\/2119271\/22\/logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/hematology-collaboration-and-licensing-partnering-analysis-report-2024-with-directory-of-deals-signed-since-2016-researchandmarkets-com\/","url":"https:\/\/pharma-trend.com\/en\/hematology-collaboration-and-licensing-partnering-analysis-report-2024-with-directory-of-deals-signed-since-2016-researchandmarkets-com\/","name":"Hematology Collaboration and Licensing Partnering Analysis Report 2024 with Directory of Deals Signed Since 2016 - ResearchAndMarkets.com - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/hematology-collaboration-and-licensing-partnering-analysis-report-2024-with-directory-of-deals-signed-since-2016-researchandmarkets-com\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/hematology-collaboration-and-licensing-partnering-analysis-report-2024-with-directory-of-deals-signed-since-2016-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20240503117955\/en\/2119271\/22\/logo.jpg","datePublished":"2024-05-03T17:03:21+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/hematology-collaboration-and-licensing-partnering-analysis-report-2024-with-directory-of-deals-signed-since-2016-researchandmarkets-com\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/hematology-collaboration-and-licensing-partnering-analysis-report-2024-with-directory-of-deals-signed-since-2016-researchandmarkets-com\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/hematology-collaboration-and-licensing-partnering-analysis-report-2024-with-directory-of-deals-signed-since-2016-researchandmarkets-com\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20240503117955\/en\/2119271\/22\/logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20240503117955\/en\/2119271\/22\/logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/hematology-collaboration-and-licensing-partnering-analysis-report-2024-with-directory-of-deals-signed-since-2016-researchandmarkets-com\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Hematology Collaboration and Licensing Partnering Analysis Report 2024 with Directory of Deals Signed Since 2016 &#8211; ResearchAndMarkets.com"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/59312","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=59312"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/59312\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=59312"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=59312"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=59312"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}